Beside the fact that HE4 could segregate a sub-group of patients with shorter survival, its prognostic value suggests that HE4 secretion might play a role in NSCLC progression, like in ovarian cancer [37]. The gene discussed is WFDC2; the disease is non-small cell lung carcinoma.